In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 6.89 below Definium Therapeutics Inc average.

Within Legal Cannabis industry only one company has achieved higher Quick Ratio in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 341 to 406.

Explain Quick Ratio?
How much Cash & cash equivalents DFTX�s has?
What are DFTX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DFTX Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	726.82 %	129.87 %	73.82 %	147.98 %	70.26 %
Y / Y Cash & cash equivalent Change	492.31 %	75.78 %	50.36 %	-29.2 %	-24.74 %
Quick Ratio MRQ	6.89	11.8	15.96	7.7	9.62
DFTX's Total Ranking	# 406	# 341	# 652	# 546	# 362
Seq. Current Liabilities Change	396.84 %	22.67 %	-4.97 %	42.75 %	38.13 %
Seq. Cash & cash equivalent Change	190.26 %	-9.27 %	96.87 %	14.25 %	-13.86 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Legal Cannabis Industry	# 2
Consumer Non Cyclical Sector	# 10
Overall Market	# 641

Quick Ratio Statistics
High	Average	Low
26.98	15.04	6.31
(Sep 30 2024)		(Jun 30 2023)

Financial Statements
Definium Therapeutics Inc 's Current Liabilities	$ 157 Millions	Visit DFTX's Balance sheet
Definium Therapeutics Inc 's Cash & cash equivalent	$ 1,084 Millions	Visit DFTX's Balance sheet
Source of DFTX's Sales		Visit DFTX's Sales by Geography

Cumulative Definium Therapeutics Inc 's Quick Ratio

DFTX's Quick Ratio for the trailling 12 Months

DFTX Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	312.86 %	104.25 %	57.21 %	34.82 %	-5.77 %
Y / Y Cash & cash equivalent TTM Growth	115.45 %	14.88 %	-4.55 %	-1.37 %	35.29 %
Quick Ratio TTM	8.59	11.36	11.85	11.75	16.47
Total Ranking TTM	# 662	# 862	# 503	# 236	# 170
Seq. Current Liabilities TTM Growth	133.4 %	20.86 %	14.65 %	27.66 %	15.47 %
Seq. Cash & cash equivalent TTM Growth	76.54 %	15.84 %	15.7 %	-8.94 %	-5.87 %

Quick ratio ranking by company, industry and sector >> Back to DFTX Financial Strength Comparisons >> Go to Compare DFTX Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q2 2026 to $157.20 millions, cumulative Quick Ratio decreased to 8.59 above the DFTX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Legal Cannabis industry 15 other companies have achieved higher Quick Ratio than Definium Therapeutics Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3652.

Explain Quick Ratio?
How much Cash & cash equivalents DFTX�s has?
What are DFTX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Legal Cannabis Industry	# 16
Consumer Non Cyclical Sector	# 143
Within the Market	# 406

trailing twelve months Quick Ratio Statistics
High	Average	Low
7.01	4.46	1.96
(Mar 31 2023)		(Dec 31 2025)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Legal Cannabis Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Cronos Group Inc	14.14	$ 797.019 Millions	$ 56.364 Millions
Definium Therapeutics Inc	6.89	$ 1,083.879 Millions	$ 157.204 Millions
Usana Health Sciences Inc	1.60	$ 168.560 Millions	$ 105.675 Millions

Date modified: 2026-09-12T06:26:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.